News Conference News ESC 2023 ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More Michael O'Riordan September 06, 2023
News Conference News SCAI 2023 Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis L.A. McKeown May 22, 2023
News Daily News Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2 Yael L. Maxwell November 03, 2022
News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News ESC 2018 GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI Michael O'Riordan August 27, 2018
News Daily News ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes Todd Neale August 17, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI Yael L. Maxwell December 22, 2015
News Daily News El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM Yael L. Maxwell December 22, 2015